Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pirmettis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 3, 2012
Synthesis, characterization and biological evaluation of novel neutral fac-M(CO)3(SNO) complexes (M=Re, 99mTc) bearing the o-methoxyphenylpiperazine moietyA Chiotellis, C Tsoukalas, M Pelecanou, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 29, 2001
Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand systemP Bouziotis, I Pirmettis, M Pelecanou, et al.
Nuclear Medicine and Biology|November 17, 2001
Ester-modified 99mTcO[SN(R)S/S] mixed ligand complexes: synthesis and preliminary evaluationC Tsoukalas, I Pirmettis, G Patsis, et al.
Investigational New Drugs|January 13, 2022
Biological evaluation of complexes of cyclopentadienyl M(CO)<sub>3</sub><sup>+</sup> (M = Re, <sup>99m</sup>Tc) with high blood-brain barrier penetration potential as brain cancer agentsB Mavroidi, A Kaminari, K Makrypidi, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Synthesis of oxorhenium(V) and oxotechnetium(V) [SN(R)S/S] mixed ligand complexes containing a phenothiazine moiety on the tridentate SN(R)S ligandI Pirmettis, G Patsis, M Pelecanou, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 11, 2001
Novel lipophilic amidate oxorhenium and oxotechnetium complexes as potential brain agents: synthesis, characterization and biological evaluationM Papadopoulos, B Nock, T Maina, et al.
Inorganic Chemistry|June 7, 2005
(S)-(2-(2'-Pyridyl)ethyl)cysteamine and (S)-(2-(2'-pyridyl)ethyl)-d,l-homocysteine as ligands for the "fac-[M(CO)(3)](+)" (M = Re, (99m)Tc) coreO Karagiorgou, G Patsis, M Pelecanou, et al.
Nuclear Medicine and Biology|November 28, 2002
Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agentsD Papagiannopoulou, I Pirmettis, Ch Tsoukalas, et al.
Inorganic Chemistry|February 24, 2001
Synthesis and characterization of mixed-ligand oxorhenium complexes with the SNN type of ligand. Isolation of a novel ReO[SN][S][S] complexA Rey, I Pirmettis, M Pelecanou, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 24, 2001
Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agentsD Papagiannopoulou, I Pirmettis, T Maina, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 3, 2012
Synthesis, characterization and biological evaluation of novel neutral fac-M(CO)3(SNO) complexes (M=Re, 99mTc) bearing the o-methoxyphenylpiperazine moietyA Chiotellis, C Tsoukalas, M Pelecanou, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 29, 2001
Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand systemP Bouziotis, I Pirmettis, M Pelecanou, et al.
Nuclear Medicine and Biology|November 17, 2001
Ester-modified 99mTcO[SN(R)S/S] mixed ligand complexes: synthesis and preliminary evaluationC Tsoukalas, I Pirmettis, G Patsis, et al.
Investigational New Drugs|January 13, 2022
Biological evaluation of complexes of cyclopentadienyl M(CO)<sub>3</sub><sup>+</sup> (M = Re, <sup>99m</sup>Tc) with high blood-brain barrier penetration potential as brain cancer agentsB Mavroidi, A Kaminari, K Makrypidi, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Synthesis of oxorhenium(V) and oxotechnetium(V) [SN(R)S/S] mixed ligand complexes containing a phenothiazine moiety on the tridentate SN(R)S ligandI Pirmettis, G Patsis, M Pelecanou, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 11, 2001
Novel lipophilic amidate oxorhenium and oxotechnetium complexes as potential brain agents: synthesis, characterization and biological evaluationM Papadopoulos, B Nock, T Maina, et al.
Inorganic Chemistry|June 7, 2005
(S)-(2-(2'-Pyridyl)ethyl)cysteamine and (S)-(2-(2'-pyridyl)ethyl)-d,l-homocysteine as ligands for the "fac-[M(CO)(3)](+)" (M = Re, (99m)Tc) coreO Karagiorgou, G Patsis, M Pelecanou, et al.
Nuclear Medicine and Biology|November 28, 2002
Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agentsD Papagiannopoulou, I Pirmettis, Ch Tsoukalas, et al.
Inorganic Chemistry|February 24, 2001
Synthesis and characterization of mixed-ligand oxorhenium complexes with the SNN type of ligand. Isolation of a novel ReO[SN][S][S] complexA Rey, I Pirmettis, M Pelecanou, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 24, 2001
Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agentsD Papagiannopoulou, I Pirmettis, T Maina, et al.
Pageof 2